The article on BIBN4096BS (Olcegepant), the first potent and selective nonpeptide calcitonin gene-related peptide 1 (CGRP1) receptor antagonist, stands out as a significant contribution to the field of CGRP receptor antagonists in migraine (41). This evidence concerns the gene CALCA and migraine disorder.